Welcome to the CJU website » LOG IN


First Prev Page 1 of 1 Next Last
  • How I do it: percutaneous radiofrequency ablation (RFA)

    Sorokin Igor, Chamarthy Murthy, Cadeddu A. Jeffrey, MD Department of Urology, UT Southwestern Medical Center, Dallas, Texas, USA

    Percutaneous radiofrequency ablation has seen increased utilization secondary to the rising incidence of renal cell carcinoma. This has been shown to be an effective and durable treatment especially in the elderly comorbid patient. In this article, we describe our technique and factors related to successful outcomes.

    Keywords: percutaneous radiofrequency ablation, RFA, thermal ablation, renal mass, kidney cancer, renal cell carcinoma,

    Feb 2017 (Vol. 24, Issue 1 , Page 8679)
First Prev Page 1 of 1 Next Last

Current Issue

April 2020, Vol.27 No.2
canadian journal of urology